Orbit Discovery – a new spinout from the University of Oxford – has raised seed funding to commercialise technology which will help to identify targeted, affordable therapeutic drugs known as peptides.

© 123dartist - Shutterstock

Image courtesy of Shutterstock

Oxford Sciences Innovation, the £320m investment company established to provide capital and scaling expertise to Oxford spinouts, is the lead investor in the new company. Other investors include the Oxford Technology and Innovations EIS Fund led by George Robinson and the OT(S)EIS fund managed by Oxford Technology management, which has been making science investments around Oxford for 30 years.

Read more